StockData
InspireMD, Inc. logo

InspireMD, Inc. (NSPR) stock

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.69+0.04 (+5.48%)

Close on Nov 18, 2026Market cap $31.87MP/E –Yield –

InspireMD net income

Net income is the profit left for shareholders after every expense, interest and tax.

InspireMD's net income for the twelve months ending Jun 30, 2026 was -$52.48M. For fiscal 2025 it was -$48.79M. The highest annual figure on record is -$2.72M in fiscal 2009.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$48.79M–
FY2024Dec 31, 2024-$32.01M–
FY2023Dec 31, 2023-$19.92M–
FY2022Dec 31, 2022-$18.49M–
FY2021Dec 31, 2021-$14.92M–
FY2020Dec 31, 2020-$10.54M–
FY2019Dec 31, 2019-$10.04M–
FY2018Dec 31, 2018-$7.24M–
FY2017Dec 31, 2017-$8.44M–
FY2016Dec 31, 2016-$8.46M–
FY2015Dec 31, 2015-$15.59M–
FY2013Jun 30, 2013-$29.26M–
FY2010Dec 31, 2010-$3.42M–
FY2009Dec 31, 2009-$2.72M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$14.32M–
Q1 FY2026Mar 31, 2026-$13.69M–
Q4 FY2025Dec 31, 2025-$11.76M–
Q3 FY2025Sep 30, 2025-$12.71M–
Q2 FY2025Jun 30, 2025-$13.15M–
Q1 FY2025Mar 31, 2025-$11.17M–
Q4 FY2024Dec 31, 2024-$9.17M–
Q3 FY2024Sep 30, 2024-$7.89M–
Q2 FY2024Jun 30, 2024-$7.91M–
Q1 FY2024Mar 31, 2024-$7.03M–
Q4 FY2023Dec 31, 2023-$5.41M–
Q3 FY2023Sep 30, 2023-$5.18M–
Q2 FY2023Jun 30, 2023-$5.08M–
Q1 FY2023Mar 31, 2023-$4.26M–
Q4 FY2022Dec 31, 2022-$4.85M–
Q3 FY2022Sep 30, 2022-$4.53M–
Q2 FY2022Jun 30, 2022-$4.64M–
Q1 FY2022Mar 31, 2022-$4.48M–
Q4 FY2021Dec 31, 2021-$4.10M–
Q3 FY2021Sep 30, 2021-$4.07M–
Q2 FY2021Jun 30, 2021-$3.51M–
Q1 FY2021Mar 31, 2021-$3.24M–
Q4 FY2020Dec 31, 2020-$3.85M–
Q3 FY2020Sep 30, 2020-$2.23M–
Q2 FY2020Jun 30, 2020-$2.48M–
Q1 FY2020Mar 31, 2020-$1.98M–
Q4 FY2019Dec 31, 2019-$2.56M–
Q3 FY2019Sep 30, 2019-$2.07M–
Q2 FY2019Jun 30, 2019-$2.21M–
Q1 FY2019Mar 31, 2019-$3.21M–
Q4 FY2018Dec 31, 2018-$2.21M–
Q3 FY2018Sep 30, 2018-$2.01M–
Q2 FY2018Jun 30, 2018-$627.00K–
Q1 FY2018Mar 31, 2018-$2.39M–
Q4 FY2017Dec 31, 2017-$1.50M–
Q3 FY2017Sep 30, 2017-$2.09M–
Q2 FY2017Jun 30, 2017-$2.29M–
Q1 FY2017Mar 31, 2017-$2.56M–
Q4 FY2016Dec 31, 2016-$2.27M–
Q3 FY2016Sep 30, 2016-$2.00M–

More InspireMD figures

See a number that looks wrong?